SPOTLIGHT -
Pharma 2023: Vaccines Journey to the Consumer
Stefan Merlo, Vice President, Commercial Development, CSL Seqirus discusses how COVID-19 has evolved the discussion of vaccines and the long-term concerns stemming from flu vaccine fatigue.
Pharma 2023: Working with Patient Advocacy Groups
Rebecca Vermeulen, VP Global Patient Networks, Product Development Medical Affairs for Roche discusses how they approach patient engagement.
Pharma 2023: Marketing to the Masses
Digital and innovation leader takes issue with the current state of pharma marketing and suggests new approaches are needed.
Pharma 2023: Digital Health Key Takeaways
Industry insights on how pharma is faring in tapping new innovations and approaches in digital health.
Pharma 2023: Unleash RWE Benefits Along the Value Chain
Panel discusses what real-world evidence—and related patient-reporting technology—need to achieve to better influence payer decision-making.
Pharma 2023: Roche Turkey’s Digital Platform for HCPs and Patients
Tool highlights efforts to overcome the challenges of remote disease management in Turkey.
Pharma 2023: A More Collaborative Medical Affairs
Experts explore MA's evolving role and skill set in engaging effectively with clinicians and other external stakeholders.
Pharma 2023: Global Market Access is a Quickly Evolving Landscape
German laws, European VBCs, and trends in China, Brazil, and Saudi Arabia are changing the way global market access works.